Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Lynch

Showing results (11-20 of 251) with videos related to

Pageof 26
Sort By:
Neurologic Clinics|November 16, 2002
Neurogenetics. IntroductionDavid R Lynch, Jennifer M Farmer
Neuron|February 3, 2007
Picking up the pieces: the roles of functional remnants of calpain-mediated proteolysisDavid R Lynch, Amy J Gleichman
Pediatric Neurology|November 18, 2025
Friedreich AtaxiaS H Subramony, David R Lynch
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|January 6, 2005
N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological diseaseElisa A Waxman, David R Lynch
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2002
Excitotoxicity: perspectives based on N-methyl-D-aspartate receptor subtypesDavid R Lynch, Rodney P Guttmann
Nature Reviews. Neurology|March 6, 2013
Neuroimmunology: Treatment of anti-NMDA receptor encephalitis--time to be bold?Jessica A Panzer, David R Lynch
Molecular Neurobiology|September 7, 2006
Calpain and synaptic functionHai-Yan Wu, David R Lynch
Lancet (London, England)|May 6, 2014
Nicotinamide in Friedreich's ataxia: useful or not?David R Lynch, Kenneth H Fischbeck
The Lancet. Neurology|January 9, 2015
Friedreich's ataxia: the European consortiumDavid R Lynch, Susan L Perlman
Molecular Diagnosis & Therapy|June 29, 2026
Advances in Gene and Cellular Therapy in Friedreich AtaxiaMichael P Lazaropoulos, David R Lynch
Pageof 26

Showing results (11-20 of 251) with videos related to

Sort By:
Pageof 26
Neurologic Clinics|November 16, 2002
Neurogenetics. IntroductionDavid R Lynch, Jennifer M Farmer
Neuron|February 3, 2007
Picking up the pieces: the roles of functional remnants of calpain-mediated proteolysisDavid R Lynch, Amy J Gleichman
Pediatric Neurology|November 18, 2025
Friedreich AtaxiaS H Subramony, David R Lynch
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|January 6, 2005
N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological diseaseElisa A Waxman, David R Lynch
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2002
Excitotoxicity: perspectives based on N-methyl-D-aspartate receptor subtypesDavid R Lynch, Rodney P Guttmann
Nature Reviews. Neurology|March 6, 2013
Neuroimmunology: Treatment of anti-NMDA receptor encephalitis--time to be bold?Jessica A Panzer, David R Lynch
Molecular Neurobiology|September 7, 2006
Calpain and synaptic functionHai-Yan Wu, David R Lynch
Lancet (London, England)|May 6, 2014
Nicotinamide in Friedreich's ataxia: useful or not?David R Lynch, Kenneth H Fischbeck
The Lancet. Neurology|January 9, 2015
Friedreich's ataxia: the European consortiumDavid R Lynch, Susan L Perlman
Molecular Diagnosis & Therapy|June 29, 2026
Advances in Gene and Cellular Therapy in Friedreich AtaxiaMichael P Lazaropoulos, David R Lynch
Pageof 26